There are no proven prophylactic interventions for COVID-19. We systematically reviewed
the efficacy of prophylactic hydroxychloroquine for COVID-19. Studies evaluating …

Background Populations such as healthcare workers (HCW) that are unable to practice
physical distancing are at high risk of acquiring Coronavirus disease-2019 (COVID-19). In …

Background Hydroxychloroquine (HCQ) is an anti-malarial and immunomodulatory drug
considered a potential candidate for drug repurposing in COVID-19 due to their in vitro …

Background Recruitment into randomized trials of hydroxychloroquine (HCQ) for prevention
of COVID-19 has been adversely affected by a widespread conviction that HCQ is not …

Background Coronavirus disease 2019 (COVID-19), a disease that affected tens of millions
of people, upended the lives of countless individuals around the globe. The chloroquine …

Abstract Background Coronavirus disease 2019 (Covid-19) occurs after exposure to severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2). For persons who are exposed, the …

Background Hydroxychloroquine has been shown to inhibit severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) in vitro, but early clinical studies found no benefit …

BackgroundRecruitment into randomized trials of hydroxychloroquine (HCQ) for prevention
of COVID-19 has been adversely affected by a widespread conviction that HCQ is not …

Background Current strategies for preventing severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection are limited to nonpharmacologic interventions …

Objective Hydroxychloroquine has been proposed as a primary prophylactic agent against
coronavirus disease 2019 (COVID-19). This study aimed to investigate if patients treated …